Fundraising Fox

Biostax

Winter Park, US · Founded 2023 · Florida corporation · 1 known investors

Biotech

Founders & leadership

NG
Noreen GriffininExecutive
AD
Angus DalgleishExecutive
SE
Seth ElliottPresident and Chief Operating Officer
PA
Peter AronstamChief Financial Officer
FS
Fengping ShanChief Science Officer
JF
Joseph FortunakExecutive

Board

CP
Christopher PearceBoard director
ET
Edward TeraskiewiczBoard director
VB
Vincent ButtaBoard director
EY
Eugene YoukilisBoard director
NP
Nicholas PlotnikoffNon-Executive Chairman of the Board (non-voting director)

Investors · 1

Deal Boxreported

Funding

SEC filings, press & company announcements

$600K disclosed across 2 of 5 rounds · 2015–2025

▶$7.5MofferedJun 2026 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Noreen GriffinExecutive Officer
Offering amount
$7.5M
Minimum investment
$10K
First sale
Dec 2025
Incorporated
Corporation, Florida, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MofferedAug 2022 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Roscoe MooreDirector
  • Robert WilsonDirector
  • Glen FarmerExecutive Officer
  • Clifford SelskyDirector
  • Cynthia DouglasExecutive Officer
  • Noreen GriffinExecutive Officer
  • Kevin PhelpsDirector
  • Stephen WilsonExecutive Officer, Director
  • Kelly WilsonExecutive Officer
Offering amount
$5M
Minimum investment
$25K
Sales commissions
$500K
Proceeds to insiders
$120K
Placement agents
JBCG Enterprises, Dealbox
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedAug 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cynthia DouglasExecutive Officer
  • Stephen WilsonExecutive Officer, Director
  • Clifford SelskyDirector
  • Roscoe MooreDirector
  • Kevin PhelpsDirector
  • Robert WilsonDirector
Offering amount
$400K
Amount sold
$400K
First sale
Jul 2022
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$200KraisedApr 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher PearceDirector
  • Edward TeraskiewiczDirector
  • Noreen GriffinExecutive Officer, Director
  • Angus DalgleishExecutive Officer
  • Vincent ButtaDirector
  • Seth ElliottExecutive Officer
  • Eugene YoukilisDirector
  • Nicholas PlotnikoffDirector
  • Peter AronstamExecutive Officer
  • Fengping ShanExecutive Officer
  • Joseph FortunakExecutive Officer
Amount sold
$200K
First sale
Mar 2015
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Biostax Launches Growth Funding Round to Revitalize Affordable Healthcareprnewswire.com · May 2023DealBox, Inc announced that it has received $12 million in funding from Immune Therapeutics, Inc. | MarketScreenermarketscreener.com · May 2023TNI BioTech, Inc. announced that it expects to receive $0.53 million in funding. -July 01, 2013 at 12:00 am EDT | MarketScreenermarketscreener.com · Jul 2013

Frequently asked questions

Who are Biostax's investors?
Biostax's investors include Deal Box.
How much funding has Biostax raised?
Biostax has disclosed $600K raised across 2 of its 5 known rounds.
Where is Biostax headquartered?
Biostax is headquartered in Winter Park, US.